Halobetasol Propionate
NDC 70752-119, Halobetasol Propionate, ointment, from QUAGEN PHARMACEUTICALS LLC.
- Product NDC
- 70752-119
- Status
- Listed
- Labeler
- QUAGEN PHARMACEUTICALS LLC
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213560
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70752-119 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HALOBETASOL PROPIONATE.5 mg/g
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70752-119-02 | 70752011902 | 1 TUBE in 1 CARTON (70752-119-02) / 15 g in 1 TUBE |
| 70752-119-04 | 70752011904 | 1 TUBE in 1 CARTON (70752-119-04) / 50 g in 1 TUBE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/fd4ebec1-e5ba-46cc-9627-4645a7b3bf19NADAC price for package 70752011902
GET /v1/drugs/nadac/70752011902NADAC price for package 70752011904
GET /v1/drugs/nadac/70752011904
Use it
Look up 70752-119 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70752-119 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70752-119. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.